A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
Public ClinicalTrials.gov record NCT02814019. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Double-blind, Randomized, Placebo-Controlled Study Assessing the Efficacy, Safety and Tolerability of Idebenone in Patients With Duchenne Muscular Dystrophy Receiving Glucocorticoid Steroids
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to assess the efficacy of idebenone in delaying the loss of respiratory function in patients with DMD receiving concomitant glucocorticoid steroids
Study identification
- NCT ID
- NCT02814019
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 255 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 10 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2016 (Type not available)
- Primary completion
- Dec 1, 2020 (Actual)
- Completion
- Dec 1, 2020 (Actual)
- Last update posted
- Dec 3, 2021
2016 – 2020
United States locations
- U.S. sites
- 20
- U.S. states
- 15
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama | Birmingham | Alabama | 35233 | — |
| Phoenix Children's Hospital | Phoenix | Arizona | 85016 | — |
| Banner University of Arizona Medical Center | Tucson | Arizona | 85724 | — |
| Childrens Hospital of Los Angeles | Los Angeles | California | 90027 | — |
| David Geffen School of Medicine at UCLA | Los Angeles | California | 90095 | — |
| UC Davis Department of Physical Medicine and Rehabilitation | Sacramento | California | 95817 | — |
| Loma Linda University Healthcare | San Bernardino | California | 92354 | — |
| Shriners Hospitals for Children-Tampa | Tampa | Florida | 33612 | — |
| Rare Disease Research | Atlanta | Georgia | 30318 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| University of Kansas | Fairway | Kansas | 66103 | — |
| Johns Hopkins University | Baltimore | Maryland | 21287 | — |
| Children's Hospital Boston | Boston | Massachusetts | 02115 | — |
| Gillette Children's Specialty Healthcare | Saint Paul | Minnesota | 55101 | — |
| University of Rochester Medical Center | Rochester | New York | 14642 | — |
| Neurosciences Institute, Neurology - Charlotte Carolinas Healthcare System | Charlotte | North Carolina | 28207 | — |
| Cincinnati Children's Hospital | Cincinnati | Ohio | 45229-3039 | — |
| MetroHealth Medical Center | Cleveland | Ohio | 44109-1988 | — |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104-1771 | — |
| Cook Children's Medical Center | Fort Worth | Texas | 76087 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 43 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02814019, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 3, 2021 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02814019 live on ClinicalTrials.gov.